ATE498396T1 - Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes - Google Patents

Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes

Info

Publication number
ATE498396T1
ATE498396T1 AT08013091T AT08013091T ATE498396T1 AT E498396 T1 ATE498396 T1 AT E498396T1 AT 08013091 T AT08013091 T AT 08013091T AT 08013091 T AT08013091 T AT 08013091T AT E498396 T1 ATE498396 T1 AT E498396T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical formulation
digestive tract
upper digestive
antiinflammatory
Prior art date
Application number
AT08013091T
Other languages
German (de)
English (en)
Inventor
Markus Proels
Rudolf Wilhelm
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE498396(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Application granted granted Critical
Publication of ATE498396T1 publication Critical patent/ATE498396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT08013091T 2008-07-21 2008-07-21 Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes ATE498396T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08013091A EP2151235B1 (de) 2008-07-21 2008-07-21 Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes

Publications (1)

Publication Number Publication Date
ATE498396T1 true ATE498396T1 (de) 2011-03-15

Family

ID=39951664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08013091T ATE498396T1 (de) 2008-07-21 2008-07-21 Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes

Country Status (23)

Country Link
US (2) US8580300B2 (enExample)
EP (2) EP2151235B1 (enExample)
JP (2) JP5616889B2 (enExample)
CN (1) CN102159196B (enExample)
AT (1) ATE498396T1 (enExample)
AU (1) AU2009273361B2 (enExample)
CA (1) CA2731312C (enExample)
CY (2) CY1111878T1 (enExample)
DE (1) DE502008002621D1 (enExample)
DK (2) DK2151235T3 (enExample)
EA (1) EA018465B1 (enExample)
ES (2) ES2358158T3 (enExample)
HR (2) HRP20130171T1 (enExample)
IL (1) IL210779A (enExample)
ME (2) ME01256B (enExample)
NZ (1) NZ590593A (enExample)
PL (2) PL2151235T3 (enExample)
PT (2) PT2151235E (enExample)
RS (2) RS51649B (enExample)
SI (2) SI2151235T1 (enExample)
UA (1) UA100759C2 (enExample)
WO (1) WO2010009961A1 (enExample)
ZA (1) ZA201100283B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) * 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
RU2246293C2 (ru) 1999-06-14 2005-02-20 Космо С.П.А. Фармацевтические композиции для перорального введения с регулируемым высвобождением активного ингредиента и маскируемым вкусом
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
ES2358158T3 (es) * 2008-07-21 2011-05-06 Dr. Falk Pharma Gmbh Formulación farmacéutica para el tratamiento del tracto digestivo superior.
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
RS59241B1 (sr) 2009-10-01 2019-10-31 Adare Development I L P Kortikosteroidne kompozicije za oralnu administraciju
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
RS58543B2 (sr) 2013-12-23 2023-02-28 Dr Falk Pharma Gmbh Optimizovana farmaceutska formulacija za lečenje zapaljenskih promena ezofagusa
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP3818789B2 (ja) * 1999-02-18 2006-09-06 三菱化学フーズ株式会社 易崩壊性錠剤
JP4038772B2 (ja) 2001-07-11 2008-01-30 敏朗 関根 光合成微生物の培養方法と装置
CN1578657A (zh) * 2001-09-25 2005-02-09 兰贝克赛实验室有限公司 制备快速溶解剂型的方法
WO2003043518A2 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060013873A1 (en) * 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
US20070191599A1 (en) * 2006-02-15 2007-08-16 Verus Pharmaceuticals, Inc. Methods of manufacturing cortiscosteroid solutions
PL2170348T3 (pl) * 2007-06-22 2017-01-31 Dompé Farmaceutici S.P.A. Tabletki musujące do zastosowania wziewnego
CA2703501C (en) * 2007-10-01 2017-06-13 Laboratorios Lesvi, S.L. Orodispersible tablets
ES2358158T3 (es) * 2008-07-21 2011-05-06 Dr. Falk Pharma Gmbh Formulación farmacéutica para el tratamiento del tracto digestivo superior.
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES

Also Published As

Publication number Publication date
UA100759C2 (uk) 2013-01-25
DK2306988T3 (da) 2013-03-18
JP6209495B2 (ja) 2017-10-04
US20140079646A1 (en) 2014-03-20
DK2151235T3 (da) 2011-04-11
JP2011528679A (ja) 2011-11-24
EP2151235B1 (de) 2011-02-16
WO2010009961A1 (de) 2010-01-28
US20110123460A1 (en) 2011-05-26
CY1113719T1 (el) 2016-06-22
CA2731312C (en) 2016-05-10
US8580300B2 (en) 2013-11-12
EA201100229A1 (ru) 2011-08-30
PT2151235E (pt) 2011-03-21
CA2731312A1 (en) 2010-01-28
CN102159196A (zh) 2011-08-17
PT2306988E (pt) 2013-02-15
HRP20130171T1 (hr) 2013-03-31
IL210779A0 (en) 2011-03-31
RS52662B (sr) 2013-06-28
RS51649B (sr) 2011-10-31
CN102159196B (zh) 2013-05-08
ES2358158T3 (es) 2011-05-06
NZ590593A (en) 2012-07-27
PL2306988T3 (pl) 2013-04-30
SI2151235T1 (sl) 2011-04-29
EP2306988A1 (de) 2011-04-13
CY1111878T1 (el) 2015-11-04
JP5616889B2 (ja) 2014-10-29
AU2009273361B2 (en) 2014-03-20
EP2151235A1 (de) 2010-02-10
SI2306988T1 (sl) 2013-03-29
HK1149907A1 (en) 2011-10-21
ME01494B (me) 2014-04-20
PL2151235T3 (pl) 2011-05-31
AU2009273361A1 (en) 2010-01-28
EA018465B1 (ru) 2013-08-30
ME01256B (me) 2013-06-20
JP2014221827A (ja) 2014-11-27
DE502008002621D1 (de) 2011-03-31
IL210779A (en) 2015-07-30
EP2306988B1 (de) 2013-01-09
HRP20110208T1 (hr) 2011-04-30
ES2399321T3 (es) 2013-03-27
ZA201100283B (en) 2011-10-26

Similar Documents

Publication Publication Date Title
ATE498396T1 (de) Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes
NZ591873A (en) Co-crystals of tramadol and nsaids
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
MX354210B (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
ZA201201060B (en) Combination of an oxidant,a photosensitizer and a wound healing agent for oral disinfection and treatment or oral disease
EP2413930A4 (en) ORAL FORMULATION OF ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS BASED ON DIPHENYLSULFONAMIDE TO TREAT HIGH BLOOD PRESSURE AND DIABETIC NEPHROPATHY
MX347106B (es) Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
DE502008002255D1 (de) Arzneimittel enthaltend Fraumenmantel zur Behandlung von Endometritis, Vaginitis
ITMI20051231A1 (it) Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale
MX2013007959A (es) Formas farmaceuticas orales de amida {2-[(1s)-1-(3-etoxi-4-metoxi- fenil]-2-metansulfonil-etil]-3-oxo-2,,3-dihidro-1h-isoindol -4-il}-del acido ciclopropancarboxilico.
TN2012000075A1 (en) Co-crystals of tramadol and coxibs
DE602006012310D1 (de) An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
TWI365753B (en) Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases
ATE413870T1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
UA71564U (ru) Средство для лечения и профилактики урологических заболеваний для перорального применения
UA38368U (ru) Лечебно-профилактический фитосироп "иммуностимулин"
UA96289C2 (ru) Способ получения лекарственного средства на основе ингибитора протеаз распылительной сушкой (варианты) и препарат (варианты)
UA87052C2 (ru) Мазь на основе тиотриазолина для лечения раневого процесса во второй и третьей стадиях